Immunocore Holdings Earnings Estimate
| IMCR Stock | USD 58.47 1.16 2.02% |
Immunocore |
Immunocore Holdings Earnings Estimation Breakdown
The calculation of Immunocore Holdings' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Immunocore Holdings is estimated to be -0.36 with the future projection ranging from a low of -0.51 to a high of -0.1. Please be aware that this consensus of annual earnings estimates for Immunocore Holdings is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.51 Lowest | Expected EPS | -0.1 Highest |
Immunocore Holdings Earnings Projection Consensus
Suppose the current estimates of Immunocore Holdings' value are higher than the current market price of the Immunocore Holdings stock. In this case, investors may conclude that Immunocore Holdings is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Immunocore Holdings' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2024 | Current EPS (TTM) | |
| 0 | 46.44% | -32.22 | -0.36 | -1.4 |
Immunocore Holdings Earnings History
Earnings estimate consensus by Immunocore Holdings analysts from Wall Street is used by the market to judge Immunocore Holdings' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Immunocore Holdings' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Immunocore Holdings Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immunocore Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Immunocore Holdings Earnings per Share Projection vs Actual
Actual Earning per Share of Immunocore Holdings refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Immunocore Holdings predict the company's earnings will be in the future. The higher the earnings per share of Immunocore Holdings, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Immunocore Holdings Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Immunocore Holdings, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Immunocore Holdings should always be considered in relation to other companies to make a more educated investment decision.Immunocore Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Immunocore Holdings' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-02-28 | 2023-12-31 | -21.74 | -32.22 | -10.48 | 48 | ||
2023-11-07 | 2023-09-30 | -28.92 | 4.0 | 32.92 | 113 | ||
2023-08-10 | 2023-06-30 | -32.1 | -0.37 | 31.73 | 98 | ||
2023-05-10 | 2023-03-31 | -32.19 | -35.0 | -2.81 | 8 | ||
2023-03-01 | 2022-12-31 | 0.03 | -54.0 | -54.03 | 180100 | ||
2022-11-09 | 2022-09-30 | -29.01 | 12.0 | 41.01 | 141 | ||
2022-08-10 | 2022-06-30 | -68.48 | -14.0 | 54.48 | 79 | ||
2022-05-11 | 2022-03-31 | -85.74 | -37.0 | 48.74 | 56 | ||
2022-03-03 | 2021-12-31 | -82.21 | -91.0 | -8.79 | 10 | ||
2021-11-10 | 2021-09-30 | -0.85 | -0.93 | -0.08 | 9 | ||
2021-08-11 | 2021-06-30 | -0.95 | -1.04 | -0.09 | 9 | ||
2021-05-12 | 2021-03-31 | -0.83 | -0.92 | -0.09 | 10 | ||
2021-03-25 | 2020-12-31 | -1.05 | -0.82 | 0.23 | 21 | ||
2020-09-30 | 2020-06-30 | 0 | -0.0041 | -0.0041 | 0 | ||
2020-06-30 | 2020-03-31 | 0 | -0.0043 | -0.0043 | 0 | ||
2020-03-31 | 2019-12-31 | 0 | -0.0043 | -0.0043 | 0 | ||
2019-12-31 | 2019-09-30 | 0 | -13.6714 | -13.6714 | 0 | ||
2019-09-30 | 2019-06-30 | 0 | -0.0074 | -0.0074 | 0 | ||
2019-06-30 | 2019-03-31 | 0 | -0.0077 | -0.0077 | 0 | ||
2019-03-31 | 2018-12-31 | 0 | -0.0079 | -0.0079 | 0 |
About Immunocore Holdings Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Immunocore Holdings earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Immunocore Holdings estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Immunocore Holdings fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -744.7 M | -707.4 M | |
| Earnings Yield | (0.000017) | (0.000017) | |
| Price Earnings Ratio | -60.4 K | -57.4 K | |
| Price Earnings To Growth Ratio | 604.88 | 635.12 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.Note that the Immunocore Holdings information on this page should be used as a complementary analysis to other Immunocore Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Immunocore Stock analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Immunocore Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunocore Holdings. If investors know Immunocore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunocore Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.68) | Earnings Share (1.40) | Revenue Per Share 5.102 | Quarterly Revenue Growth 0.122 | Return On Assets (0.07) |
The market value of Immunocore Holdings is measured differently than its book value, which is the value of Immunocore that is recorded on the company's balance sheet. Investors also form their own opinion of Immunocore Holdings' value that differs from its market value or its book value, called intrinsic value, which is Immunocore Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunocore Holdings' market value can be influenced by many factors that don't directly affect Immunocore Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunocore Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunocore Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunocore Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.